Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 CAD | -3.23% | -4.76% | -7.69% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 4.069 | 2.392 | 1.914 | 3.71 | 17.45 | 8.591 |
Enterprise Value (EV) 1 | 44.25 | 23.1 | 14.54 | 27.6 | 57.04 | 40.23 |
P/E ratio | -0.43 x | -0.65 x | -0.36 x | 3.1 x | 2.02 x | 10.8 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.03 x | 0.03 x | 0.04 x | 0.06 x | 0.17 x | 0.08 x |
EV / Revenue | 0.36 x | 0.25 x | 0.32 x | 0.46 x | 0.55 x | 0.38 x |
EV / EBITDA | 11.6 x | 10.2 x | -6.61 x | 8.31 x | 6.77 x | 7.92 x |
EV / FCF | 44.8 x | 1.03 x | 1.34 x | -2.46 x | -3.59 x | 5.11 x |
FCF Yield | 2.23% | 96.7% | 74.7% | -40.7% | -27.8% | 19.6% |
Price to Book | 0.2 x | 0.15 x | 0.18 x | 0.32 x | 0.78 x | 0.38 x |
Nbr of stocks (in thousands) | 23,933 | 23,924 | 23,924 | 23,933 | 26,433 | 26,433 |
Reference price 2 | 0.1700 | 0.1000 | 0.0800 | 0.1550 | 0.6600 | 0.3250 |
Announcement Date | 01/04/19 | 20/04/20 | 31/03/21 | 30/03/22 | 29/03/23 | 29/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 121.4 | 91.73 | 45.16 | 60.4 | 104.5 | 106 |
EBITDA 1 | 3.815 | 2.273 | -2.199 | 3.323 | 8.425 | 5.079 |
EBIT 1 | 2.749 | 1.372 | -2.737 | 2.847 | 7.824 | 4.41 |
Operating Margin | 2.26% | 1.5% | -6.06% | 4.71% | 7.49% | 4.16% |
Earnings before Tax (EBT) 1 | -7.14 | -3.641 | -5.123 | 1.287 | 4.62 | 1.407 |
Net income 1 | -9.355 | -3.656 | -5.148 | 1.317 | 8.643 | 0.9094 |
Net margin | -7.7% | -3.99% | -11.4% | 2.18% | 8.27% | 0.86% |
EPS 2 | -0.3910 | -0.1528 | -0.2200 | 0.0500 | 0.3270 | 0.0300 |
Free Cash Flow 1 | 0.987 | 22.34 | 10.87 | -11.22 | -15.87 | 7.874 |
FCF margin | 0.81% | 24.36% | 24.07% | -18.57% | -15.19% | 7.43% |
FCF Conversion (EBITDA) | 25.87% | 982.81% | - | - | - | 155.03% |
FCF Conversion (Net income) | - | - | - | - | - | 865.84% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 01/04/19 | 20/04/20 | 31/03/21 | 30/03/22 | 29/03/23 | 29/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 40.2 | 20.7 | 12.6 | 23.9 | 39.6 | 31.6 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 10.53 x | 9.11 x | -5.743 x | 7.189 x | 4.699 x | 6.229 x |
Free Cash Flow 1 | 0.99 | 22.3 | 10.9 | -11.2 | -15.9 | 7.87 |
ROE (net income / shareholders' equity) | -38.3% | -20.2% | -38.8% | 11.8% | 50.7% | 4.05% |
ROA (Net income/ Total Assets) | 2.25% | 1.47% | -4.79% | 5.08% | 8% | 3.75% |
Assets 1 | -416.2 | -249.1 | 107.6 | 25.93 | 108.1 | 24.23 |
Book Value Per Share 2 | 0.8400 | 0.6700 | 0.4400 | 0.4900 | 0.8500 | 0.8500 |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | 1.43 | 0.37 | 0 | 0.04 | 2.11 | 0.69 |
Capex / Sales | 1.18% | 0.4% | 0.01% | 0.07% | 2.02% | 0.65% |
Announcement Date | 01/04/19 | 20/04/20 | 31/03/21 | 30/03/22 | 29/03/23 | 29/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-7.69% | 6M | |
+17.69% | 66.69B | |
+1.79% | 49.2B | |
+17.80% | 41.24B | |
+20.17% | 25.89B | |
+12.56% | 19.81B | |
+2.67% | 17.11B | |
-23.12% | 15.86B | |
+2.62% | 15.35B | |
-8.19% | 15.23B |
- Stock Market
- Equities
- BRY Stock
- Financials Bri-Chem Corp.